A trial for a new itchy skin medicine for people on peritoneal dialysis
Part of Kidney & urinary, Skin clinical trials.
This trial tests if a medication called nalfurafine hydrochloride (taken as a tablet that melts in your mouth) can help reduce moderate to severe itching in people receiving peritoneal dialysis for chronic kidney disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old.
- You have chronic kidney failure and have been on peritoneal dialysis for at least 3 months.
- Your itching is not caused by other conditions like allergies, skin infections, or liver disease.
- You have not used certain medications for itching (like antihistamines, steroids, or gabapentin) recently or plan to change them during the trial.
- You do not have serious heart problems, active infections, or cancer that required treatment in the last year.
- You can understand and follow the study procedures and give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if anrikefon or nalfurafine improves sleep quality in people on hemodialysis who have chronic kidney disease-related itching. It aims to find a better treatment for both itch and sleep problems.
This trial tests a new tablet called nalfurafine to help reduce severe itching that happens in people on regular kidney dialysis. If you've had itching for a while despite trying other treatments, this study may help you and contribute to better options for dialysis patients.
This study tests a medicine called nalfurafine to see if it can reduce severe itching that many people on dialysis have. It will compare the medicine to standard care to find out if it works.
This trial tests a drug called difelikefalin to see if it safely reduces moderate-to-severe itching in teenagers who are on hemodialysis. Itching is common in kidney disease, and this study aims to find a new treatment option.
This trial tests a medication called difelikefalin to relieve severe itching in people on long-term kidney dialysis. Many dialysis patients experience persistent itching that affects their quality of life, and this study explores whether this drug can help.
This study tests a special type of dialysis filter (made of PMMA) to see if it can reduce severe itching and improve quality of life for people on long-term dialysis. If you have bothersome itching that standard treatment hasn't helped, this trial might be an option for you.
Hear when a new Adverse Event trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.